The Predictive Power of Brain mRNA Mappings for in vivo Protein Density: A Positron Emission Tomography Correlation Study

Substantial efforts are being spent on postmortem mRNA transcription mapping on the assumption that in vivo protein distribution can be predicted from such data. We tested this assumption by comparing mRNA transcription maps from the Allen Human Brain Atlas with reference protein concentration maps acquired with positron emission tomography (PET) in two representative systems of neurotransmission (opioid and serotoninergic). We found a tight correlation between mRNA expression and specific binding with 5-HT1A receptors measured with PET, but for opioid receptors, the correlation was weak. The discrepancy can be explained by differences in expression regulation between the two systems: transcriptional mechanisms dominate the regulation in the serotoninergic system, whereas in the opioid system proteins are further modulated after transcription. We conclude that mRNA information can be exploited for systems where translational mechanisms predominantly regulate expression. Where posttranscriptional mechanisms are important, mRNA data have to be interpreted with caution. The methodology developed here can be used for probing assumptions about the relationship of mRNA and protein in multiple neurotransmission systems.

[1]  A. Reymond,et al.  A High-Resolution Anatomical Atlas of the Transcriptome in the Mouse Embryo , 2011, PLoS biology.

[2]  M. Mintun,et al.  A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography , 1984, Annals of neurology.

[3]  R Todd Ogden,et al.  In vivo Serotonin-Sensitive Binding of [11C]CUMI-101: A Serotonin 1A Receptor Agonist Positron Emission Tomography Radiotracer , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[4]  L. Wodicka,et al.  Regional and strain-specific gene expression mapping in the adult mouse brain. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[5]  J. Seilhamer,et al.  A comparison of selected mRNA and protein abundances in human liver , 1997, Electrophoresis.

[6]  M. Hamon,et al.  Heterogeneous distribution of the serotonin 5‐HT1A receptor mRNA in chemically identified neurons of the mouse rostral brainstem: Implications for the role of serotonin in the regulation of wakefulness and REM sleep , 2010, The Journal of comparative neurology.

[7]  S. Gygi,et al.  Correlation between Protein and mRNA Abundance in Yeast , 1999, Molecular and Cellular Biology.

[8]  Daniel Rueckert,et al.  Automatic segmentation of brain MRIs of 2-year-olds into 83 regions of interest , 2008, NeuroImage.

[9]  Hui Jiang,et al.  How is mRNA expression predictive for protein expression? A correlation study on human circulating monocytes. , 2008, Acta biochimica et biophysica Sinica.

[10]  H. Loh,et al.  Post-transcriptional regulation of opioid receptors in the nervous system. , 2004, Frontiers in bioscience : a journal and virtual library.

[11]  T. Jones,et al.  Spectral Analysis of Dynamic PET Studies , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[12]  B. Futcher,et al.  A Sampling of the Yeast Proteome , 1999, Molecular and Cellular Biology.

[13]  Allan R. Jones,et al.  An anatomically comprehensive atlas of the adult human brain transcriptome , 2012, Nature.

[14]  G. Knudsen,et al.  Changes in 5-HT2A-mediated behavior and 5-HT2A- and 5-HT1A receptor binding and expression in conditional brain-derived neurotrophic factor knock-out mice , 2010, Neuroscience.

[15]  F. Turkheimer,et al.  Measuring endogenous changes in serotonergic neurotransmission in humans: a [11C]CUMI-101 PET challenge study , 2012, Molecular Psychiatry.

[16]  Sarah Barber,et al.  A mouse atlas of gene expression: large-scale digital gene-expression profiles from precisely defined developing C57BL/6J mouse tissues and cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[17]  S. Loening,et al.  Different mRNA and protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 in benign and malignant prostate tissue. , 2002, European urology.

[18]  R. P. Maguire,et al.  Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[19]  J. Kleinman,et al.  Spatiotemporal transcriptome of the human brain , 2011, Nature.

[20]  Alexander Hammers,et al.  Opioid Imaging. , 2007, PET clinics.

[21]  Alexander Hammers,et al.  Three‐dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe , 2003, Human brain mapping.

[22]  T. Ørntoft,et al.  Gene expression profiling: monitoring transcription and translation products using DNA microarrays and proteomics , 2000, FEBS letters.

[23]  Mitul A Mehta,et al.  Presynaptic 5-HT1A is Related to 5-HTT Receptor Density in the Human Brain , 2011, Neuropsychopharmacology.

[24]  Alexander Hammers,et al.  Multi-Scale hierarchical generation of PET parametric maps: Application and testing on a [11C]DPN study , 2010, NeuroImage.

[25]  A. Lammertsma,et al.  Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.

[26]  R. Emeson,et al.  Regulation of serotonin-2C receptor G-protein coupling by RNA editing , 1997, Nature.

[27]  David E. Misek,et al.  Discordant Protein and mRNA Expression in Lung Adenocarcinomas * , 2002, Molecular & Cellular Proteomics.

[28]  S. Yamamura,et al.  Different actions for acute and chronic administration of mirtazapine on serotonergic transmission associated with raphe nuclei and their innervation cortical regions , 2011, Neuropharmacology.

[29]  Alexander Hammers,et al.  Balancing bias, reliability, noise properties and the need for parametric maps in quantitative ligand PET: [11C]diprenorphine test–retest data , 2007, NeuroImage.

[30]  M. Gerstein,et al.  Comparing protein abundance and mRNA expression levels on a genomic scale , 2003, Genome Biology.

[31]  Allan R. Jones,et al.  Genome-wide atlas of gene expression in the adult mouse brain , 2007, Nature.

[32]  Alexey I Nesvizhskii,et al.  Protein identification by tandem mass spectrometry and sequence database searching. , 2007, Methods in molecular biology.

[33]  Matthew A. Zapala,et al.  Adult mouse brain gene expression patterns bear an embryologic imprint. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Timothy Wilkes,et al.  Microarray data quality - review of current developments. , 2007, Omics : a journal of integrative biology.

[35]  J. Yates,et al.  An automated multidimensional protein identification technology for shotgun proteomics. , 2001, Analytical chemistry.

[36]  R. Matthiesen Mass Spectrometry Data Analysis in Proteomics , 2006, Methods in Molecular Biology.